165 related articles for article (PubMed ID: 30275913)
1. Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection.
Wang ZY; Li HY; Wang H; Chi Q; Liu Y; Li XM
Dis Markers; 2018; 2018():5609395. PubMed ID: 30275913
[TBL] [Abstract][Full Text] [Related]
2. Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.
Feng CC; Wang PH; Guan M; Jiang HW; Wen H; Ding Q; Wu Z
Folia Biol (Praha); 2011; 57(6):242-7. PubMed ID: 22264718
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.
Konety BR; Nguyen TS; Brenes G; Sholder A; Lewis N; Bastacky S; Potter DM; Getzenberg RH
J Urol; 2000 Sep; 164(3 Pt 1):634-9. PubMed ID: 10953114
[TBL] [Abstract][Full Text] [Related]
4. BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.
Cui L; Sun MM; Zhao ZH; Yang JP; Zheng YP; He LL; Chen KS; Fan QX
J Biol Regul Homeost Agents; 2016; 30(2):485-90. PubMed ID: 27358136
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.
Xiao Y; Ju L; Qian K; Jin W; Wang G; Zhao Y; Jiang W; Liu N; Wu K; Peng M; Cao R; Li S; Shi H; Gong Y; Zheng H; Liu T; Luo Y; Ma H; Chang L; Li G; Cao X; Tian Y; Xu Z; Yang Z; Shan L; Guo Z; Yao D; Zhou X; Chen X; Guo Z; Liu D; Xu S; Ji C; Yu F; Hong X; Luo J; Cao H; Zhang Y; Wang X
Clin Transl Med; 2022 Aug; 12(8):e1008. PubMed ID: 35968916
[TBL] [Abstract][Full Text] [Related]
6. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
Wang Z; Li H; Chi Q; Qiu Y; Li X; Xin L
Med Sci Monit; 2018 Jun; 24():3882-3887. PubMed ID: 29883442
[TBL] [Abstract][Full Text] [Related]
8. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Konety BR; Nguyen TS; Dhir R; Day RS; Becich MJ; Stadler WM; Getzenberg RH
Clin Cancer Res; 2000 Jul; 6(7):2618-25. PubMed ID: 10914702
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
10. Detection of bladder cancer with aberrantly fucosylated ITGA3.
Islam MK; Syed P; Dhondt B; Gidwani K; Pettersson K; Lamminmäki U; Leivo J
Anal Biochem; 2021 Sep; 628():114283. PubMed ID: 34102169
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.
Szymańska B; Sawicka E; Guzik A; Zdrojowy R; Długosz A
Biomed Res Int; 2017; 2017():9643139. PubMed ID: 28929116
[TBL] [Abstract][Full Text] [Related]
12. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
[TBL] [Abstract][Full Text] [Related]
13. Highly specific urine-based marker of bladder cancer.
Van Le TS; Miller R; Barder T; Babjuk M; Potter DM; Getzenberg RH
Urology; 2005 Dec; 66(6):1256-60. PubMed ID: 16360453
[TBL] [Abstract][Full Text] [Related]
14. Use of the novel marker BLCA-1 for the detection of bladder cancer.
Myers-Irvin JM; Landsittel D; Getzenberg RH
J Urol; 2005 Jul; 174(1):64-8. PubMed ID: 15947579
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.
Dugas SG; Müller DC; Le Magnen C; Federer-Gsponer J; Seifert HH; Ruiz C; Savic Prince S; Vlajnic T; Zellweger T; Mertz KD; Bacon JVW; Wyatt AW; Rentsch CA; Bubendorf L
Cancer Cytopathol; 2019 Sep; 127(9):578-585. PubMed ID: 31386310
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
18. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
[TBL] [Abstract][Full Text] [Related]
19. Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.
Wolfs JRE; Hermans TJN; Koldewijn EL; van de Kerkhof D
Urol Oncol; 2021 Mar; 39(3):161-170. PubMed ID: 33376063
[TBL] [Abstract][Full Text] [Related]
20. Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Martins-Lima C; Miranda-Gonçalves V; Lobo J; Constâncio V; Leite-Silva P; Guimarães-Teixeira C; Monteiro-Reis S; Sequeira JP; Cantante M; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
Cell Oncol (Dordr); 2022 Feb; 45(1):135-149. PubMed ID: 35064910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
